Literature DB >> 3059889

Pentoxifylline decreases endotoxin-induced pulmonary neutrophil sequestration and extravascular protein accumulation in the dog.

C H Welsh1, D Lien, G S Worthen, J V Weil.   

Abstract

Since neutrophils may be important in endotoxin-induced acute lung injury, we sought to determine whether injury produced by endotoxin in vivo would be modified by pentoxifylline, which decreases neutrophil adherence and lessens neutrophil activation in vitro. Anesthetized dogs received 4 micrograms/kg Salmonella enteriditis endotoxin intravenously after pretreatment with either saline or pentoxifylline 20 mg/kg intravenously administered followed by a continuous 0.1 mg/kg/min infusion. Two hours after endotoxin, pulmonary vascular permeability to protein was assessed as the lung extravascular accumulation of intravenously administered 113mIn-transferrin. Results expressed as the ratio of extra- to intravascular protein activities showed a clear increase over control values in dogs treated with endotoxin [0.064 +/- 0.003 (mean +/- SEM) and 0.31 +/- 0.14 respectively, p less than 0.05]. This increase with endotoxin was reversed by pentoxifylline to levels similar to control values (0.063 +/- 0.044, p less than 0.05). To determine whether pentoxifylline influenced neutrophil sequestration, thin sections of lung tissue were analyzed for neutrophil density using an intercept counting technique. Neutrophil density was doubled in dogs treated with endotoxin over that seen in controls (0.078 +/- 0.008 versus 0.042 +/- 0.006 neutrophils per alveolar septa, respectively, p less than 0.05) and this increase was significantly reduced by pentoxifylline treatment (0.048 +/- 0.009, p less than 0.05). Endotoxin increased lung retention of radiolabeled neutrophils and this was also prevented by pretreatment of the neutrophils with pentoxifylline. In summary, pentoxifylline decreases neutrophil accumulation and prevents the increase in pulmonary vascular permeability to protein induced by endotoxin. These data support the premise that pentoxifylline is protective against endotoxin-induced lung injury in vivo.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3059889     DOI: 10.1164/ajrccm/138.5.1106

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  16 in total

Review 1.  The pulmonary physician and critical care. 3. Pharmacotherapy in lung injury.

Authors:  M Messent; M J Griffiths
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139

2.  Pentoxifylline in septic shock.

Authors:  P S Sarma
Journal:  Postgrad Med J       Date:  1990-11       Impact factor: 2.401

Review 3.  The adult respiratory distress syndrome.

Authors:  N F Voelkel
Journal:  Klin Wochenschr       Date:  1989-06-01

4.  Cellular mechanisms of acute lung injury: implications for future treatment in the adult respiratory distress syndrome.

Authors:  S C Donnelly; C Haslett
Journal:  Thorax       Date:  1992-04       Impact factor: 9.139

5.  Pentoxifylline inhibits superantigen-induced toxic shock and cytokine release.

Authors:  T Krakauer; B G Stiles
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

Review 6.  The role of the microcirculation in multiple organ dysfunction syndrome (MODS): a review and perspective.

Authors:  C J Kirkpatrick; F Bittinger; C L Klein; S Hauptmann; B Klosterhalfen
Journal:  Virchows Arch       Date:  1996-02       Impact factor: 4.064

7.  The effect of pentoxifylline on the healing of intestinal anastomosis in rats with experimental obstructive jaundice.

Authors:  M Cömert; F Taneri; E Tekin; E Ersoy; S Oktemer; E Onuk; E Düzgün; F Ayoğlu
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

8.  Pentoxifylline modulation of plasma membrane functions in human polymorphonuclear leukocytes.

Authors:  W L Hand; M L Butera; N L King-Thompson; D L Hand
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

9.  Pentoxifylline modulates meningeal inflammation in experimental bacterial meningitis.

Authors:  X Sáez-Llorens; O Ramilo; M M Mustafa; J Mertsola; C de Alba; E Hansen; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

10.  Pentoxifylline attenuates acute lung injury induced by microemboli.

Authors:  C Y Shen; K Hsu; D Wang; H C Yan
Journal:  Experientia       Date:  1995-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.